Chiltern may be better known in the industry for our temperature controlled storage and distribution of food and food products throughout the UK and Europe. However, Chiltern has been working with the NHS for the past three years delivering lifesaving drugs to hospitals in the UK.
The National Institute for Health Research (NIHR) Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, supports translational research into new ways of treating patients with unmet needs. Organ transplant recipients receive life-long treatment with immune suppressive drugs, leading to life-threatening complications like opportunistic infection and heart disease. The NHS’s work with cryopreserved cell therapies aims to manipulate the immune system of liver and kidney transplant patients to tolerate the transplanted organ, freeing them from immune suppression.
Clinical trials take place at Guy’s and St Thomas’ and King’s College Hospitals in London, and Churchill Hospital in Oxford. Chiltern manages the supply transportation of the cells in temperature controlled sprinter vans from the Guy’s manufacturing site.
Chiltern are experts in providing unique pharmaceutical, medical, clinical trial and life science services. Storing and distributing life-saving products is an immense responsibility and product integrity cannot be compromised.
Nick Maskrey, Pharmaceutical Manager says: “We are extremely proud to have been working in partnership with the NIHR Biomedical Research Centre at Guys and St Thomas’ hospital for a number of years. Chiltern fully understands the exacting supply chain requirements that our valued customer expects at all times.”